A New Approach to the Classification of Idiopathic Inflammatory MyopathyLori A. Love, Frederick W. Miller, Richard L. Leff et al.|Medicine|1991Cited by 974
Drug therapy of the idiopathic inflammatory myopathies: predictors of response to prednisone, azathioprine, and methotrexate and a comparison of their efficacyMarshall M. Joffe, Frederick W. Miller, Lori A. Love et al.|The American Journal of Medicine|1993Cited by 313
Immunogenetic Risk and Protective Factors for the Idiopathic Inflammatory MyopathiesTerrance P. OʼHanlon, Frederick W. Miller, Danielle M. Carrick et al.|Medicine|2006Cited by 158
Distinct seasonal patterns in the onset of adult idiopathic inflammatory myopathy in patients with anti‐jo‐1 and anti‐signal recognition particle autoantibodiesRichard L. Leff, Paul H. Plötz, Frederick W. Miller et al.|Arthritis & Rheumatism|1991Cited by 113
Antibodies to glycyl–transfer rna synthetase in patients with myositis and interstitial lung diseaseIra N. Targoff, Frederick W. Miller, Edward P. Trieu et al.|Arthritis & Rheumatism|1992Cited by 107